HomeNewsBusinessLuxury is about roots and DNA: Omega CEO

Luxury is about roots and DNA: Omega CEO

Raynald Aeschlimann believes that young customers are interested in new watches with some vintage appeal, and that stores should be non-intimidating spaces

April 18, 2021 / 10:24 IST
Story continues below Advertisement
We are finding young people are interested in new watches that have some sort of vintage appeal, Omega CEO Raynald Aeschlimann tells Moneycontrol (Image: Omega Constellation)
We are finding young people are interested in new watches that have some sort of vintage appeal, Omega CEO Raynald Aeschlimann tells Moneycontrol (Image: Omega Constellation)

Akshay Sawai

Online availability and watches with history are two key drivers to attract young customers, Omega CEO Raynald Aeschlimann believes.

Story continues below Advertisement

“We are finding young people are interested in new watches that have some sort of vintage appeal. We are not talking about simple reissues of classic watches: we are talking about modern watches that might reference the 1950s and 60s in their design,” Aeschlimann said in an interview in the April issue of ‘Monocle’.

Man stepping on the moon was a giant leap for Omega. It was the official watch of NASA missions, including Apollo XI, when Neil Armstrong, Buzz Aldrin and Michael Collins flew to the silver disc in our sky. That was 1969. Half a century later, Omega still possesses the cachet of being the first watch ever worn on the moon, of being on the hands of Armstrong and Aldrin as they registered one of mankind’s greatest achievements.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show